Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08DZZ
|
|||
| Former ID |
DIB011125
|
|||
| Drug Name |
HE2100
|
|||
| Synonyms |
Androstenediol; Hermaphrodiol; 5-Androstenediol; Androst-5-enediol; 521-17-5; Androst-5-ene-3beta,17beta-diol; Neumune; 3beta,17beta-Dihydroxyandrost-5-ene; delta(sup 5)-Androstenediol; Androstenediol [JAN]; UNII-95PS51EMXY; Androst-5-enediol (VAN); (3beta,17beta)-androst-5-ene-3,17-diol; 5-AED; 3beta,17beta-Dihydroxy-5-androstene; androst-5-en-3beta,17beta-diol; EINECS 208-306-8; NSC 12163; 95PS51EMXY; ANDROST-5-ENE-3-beta,17-beta-DIOL; CHEMBL440283; CHEBI:2710; (3-beta,17-beta)-Androst-5-ene-3,17-diol; delta(sup; ANDROSTENEDIOL
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Thrombocytopenia [ICD-11: 3B64] | Discontinued in Phase 1 | [1] | |
| Company |
Hollis-Eden Pharmaceuticals
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H30O2
|
|||
| Canonical SMILES |
CC12CCC3C(C1CCC2O)CC=C4C3(CCC(C4)O)C
|
|||
| InChI |
1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h3,13-17,20-21H,4-11H2,1-2H3/t13-,14-,15-,16-,17-,18-,19-/m0/s1
|
|||
| InChIKey |
QADHLRWLCPCEKT-LOVVWNRFSA-N
|
|||
| CAS Number |
CAS 521-17-5
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
6955, 3139522, 7847247, 8145886, 8157681, 12146100, 14897987, 14922510, 24702265, 25621407, 29229108, 48415569, 49869390, 50112747, 50804001, 53788203, 57304390, 57326355, 90451287, 92297868, 92711433, 93167092, 99453738, 103203033, 104095343, 104323845, 117557047, 126524916, 126630860, 126688967, 128993376, 134345253, 134977201, 137131402, 137900303, 144206048, 152094956, 162095576, 163398407, 170465858, 172847978, 179293163, 198966861, 223672349, 224097058, 226415063, 241090053, 250108529, 252406465
|
|||
| ChEBI ID |
CHEBI:2710
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800015080) | |||
| REF 2 | Androstene-3,5-dienes as ER-beta selective SERMs. Bioorg Med Chem Lett. 2007 Nov 15;17(22):6295-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.